A water-based biorefinery process that converts hemicellulose-rich side-streams from pectin production into bio-based furfural, an established industrial intermediate for resins, solvents and chemicals, while recovering a cellulose-rich fibre coproduct. The wet residue is processed directly, avoiding energy-intensive drying; hydrothermal fractionation and acid-catalysed dehydration of mixed pentoses produce furfural without isolating individual sugars. Designed to minimize energy, chemical inputs and waste while creating value from an agricultural residue.
This technology is an integrated, water-based route that upgrades hemicellulose-rich side-streams from pectin production. The feedstock typically contains 35–45 wt% hemicellulose and 45–50 wt% cellulose on a dry basis and arrives wet (75–85 wt% moisture), making drying energy-intensive. Instead of drying, the process treats the wet residue directly: mild hydrothermal fractionation releases hemicellulose-derived sugars while retaining a cellulose-rich fibre fraction, creating two value streams from one feedstock.
The extracted sugars are hydrolysed and then converted to furfural via acid-catalysed dehydration. Furfural is an established industrial intermediate for resins, solvents and chemicals. Individual pentoses do not need to be separated, simplifying downstream processing, and the residue's natural acidity (pH 1.8–3.0) can reduce added-acid requirements. The overall design minimizes energy use, chemical inputs and waste compared with conventional dried-residue processing.
Process steps:
Key considerations:
The separate processing steps have been demonstrated at laboratory and pilot scale: hot-water extraction of comparable depectinised plant residues has been run at pilot scale, and acid-catalysed conversion of mixed-pentose hydrolysates to furfural is established. The integrated process for this specific side-stream is at pre-pilot laboratory validation, approximately TRL 3–4. A 12-month validation plan covering feed characterisation, fractionation and conversion optimisation, pilot-relevant trials, and techno-economic assessment would advance the technology to pilot-ready status.
Monash University is a comprehensive public research university and one of Australia’s largest, known for scale, interdisciplinarity, and an applied orientation. Its Melbourne-based technology precinct brings together university laboratories, pilot-scale and prototyping suites, and company R&D groups alongside government research organizations to enable co-development and rapid iteration. Integration with a major hospital network supports clinical trials and translation, while structured industry placements and doctoral partnerships create a robust talent pipeline for corporate R&D. Research is backed by competitive funding from the Australian Research Council, the National Health and Medical Research Council, and state and federal programs that incentivize industry collaboration. A dedicated technology transfer office manages IP, licensing, and startup formation, with pathways to incubation and investment within the precinct.